Sinovac receives approval from China for its quadrivalent influenza vaccine

24 June 2020 - Sinovac Biotech today announced the China National Medical Products Administration issued a product license for its ...

Read more →

Merck’s Keytruda (pembrolizumab) approved in China for second-line treatment of patients with locally advanced or metastatic oesophageal squamous cell carcinoma whose tumours express PD-L1 (CPS ≥10)

22 June 2020 - Keytruda is now approved across five indications for three different types of cancer in China and is ...

Read more →

Dupixent (dupilumab) approved in China for adults with moderate to severe atopic dermatitis

19 June 2020 - Dupixent included in China’s list of overseas approved drugs that meet urgent clinical need. ...

Read more →

Helsinn announces launch of oral formulation of Akynzeo in China

9 June 2020 - Helsinn announces launch of oral formulation of Akynzeo in China. ...

Read more →

BeiGene announces the approval of Brukinsa (zanubrutinib) in China for patients with relapsed/refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma and relapsed/refractory mantle cell lymphoma

3 June 2020 - First approvals for Brukinsa in China and its first indication for relapsed/refractory chronic lymphocytic leukaemia/small lymphocytic lymphoma. ...

Read more →

China approves Austedo for treating chorea associated with Huntington's disease and tardive dyskinesia in adults

18 May 2020 - Teva Pharmaceutical Industries today announced that the China National Medical Products Administration has approved Austedo (deutetrabenazine tablets) ...

Read more →

Bevespi Aerosphere approved in China for patients with COPD

18 May 2020 - First approval in China of a fixed-dose, long-acting dual bronchodilator in a pressurised metered-dose inhaler device. ...

Read more →

The coronavirus exposed the US' reliance on India for generic drugs. But that supply chain is ultimately controlled by China

17 May 2020 - Sarah Thebarge, a 41-year-old physician assistant living in San Francisco, takes a pill every day to ...

Read more →

China NMPA approves Optune for the treatment of newly diagnosed and recurrent glioblastoma

13 May 2020 - Optune is the first innovative treatment for glioblastoma approved in China in over 15 years. ...

Read more →

China approves Novartis' multiple sclerosis treatment Mayzent

9 May 2020 - Chinese regulators have approved Novartis' Mayzent to treat relapsing multiple sclerosis in adults, the Swiss drug ...

Read more →

OIA response: medicines from China

11 May 2020 - PHARMAC responds as OIA request, dated 27 February 2020, asking for a list of medications made ...

Read more →

China National Medical Products Administration approves Doptelet (avatrombopag) for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure

30 April 2020 - First approval for Doptelet in China and first-ever treatment for this indication in China. ...

Read more →

Maker of drug touted as coronavirus cure accuses China of gouging

24 April 2020 - Hydroxychloroquine controversially pushed by Trump as COVID-19 remedy. ...

Read more →

China National Medical Products Administration approves BeiGene’s tislelizumab for patients with previously treated locally advanced or metastatic urothelial carcinoma

10 April 2020 - Second approval of tislelizumab in China, first in solid tumour ...

Read more →

Astellas announces acceptance of Xospata (gilteritinib) for regulatory review in China by the National Medical Products Administration

10 April 2020 - Astellas announced today a new drug application for the oral once-daily therapy Xospata (gilteritinib), for the treatment ...

Read more →